Insider Transactions in Q4 2025 at Pmv Pharmaceuticals, Inc. (PMVP)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 27
2025
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
220,643
+32.85%
|
$220,643
$1.37 P/Share
|
|
Oct 23
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-16.74%
|
$1,000,000
$1.52 P/Share
|